Advanced Quantification Methods To Improve the 18b Dormancy Model for Assessing the Activity of Tuberculosis Drugs In Vitro

ED Pieterman, MJ Sarink, ST Cole… - Antimicrobial agents …, 2020 - Am Soc Microbiol
One of the reasons for the lengthy tuberculosis (TB) treatment is the difficulty to treat the
nonmultiplying mycobacterial subpopulation. In order to assess the ability of (new) TB drugs …

Advanced Quantification Methods To Improve the 18b Dormancy Model for Assessing the Activity of Tuberculosis Drugs In Vitro.

ED Pieterman, MJ Sarink, C Sala, ST Cole… - Antimicrobial agents and …, 2020 - sonar.ch
English One of the reasons for the lengthy tuberculosis (TB) treatment is the difficulty to treat
the nonmultiplying mycobacterial subpopulation. In order to assess the ability of (new) TB …

Advanced quantification methods to improve the 18b dormancy model for assessing the activity of tuberculosis drugs In vitro.

ED Pieterman, MJ Sarink, C Sala, ST Cole… - 2020 - cabidigitallibrary.org
One of the reasons for the lengthy tuberculosis (TB) treatment is the difficulty to treat the
nonmultiplying mycobacterial subpopulation. In order to assess the ability of (new) TB drugs …

Advanced Quantification Methods To Improve the 18b Dormancy Model for Assessing the Activity of Tuberculosis Drugs In Vitro.

ED Pieterman, MJ Sarink, C Sala, ST Cole… - Antimicrobial Agents …, 2020 - europepmc.org
One of the reasons for the lengthy tuberculosis (TB) treatment is the difficulty to treat the
nonmultiplying mycobacterial subpopulation. In order to assess the ability of (new) TB drugs …

Advanced Quantification Methods To Improve the 18b Dormancy Model for Assessing the Activity of Tuberculosis Drugs In Vitro

ED Pieterman, MJ Sarink, C Sala… - Antimicrobial …, 2020 - pubmed.ncbi.nlm.nih.gov
One of the reasons for the lengthy tuberculosis (TB) treatment is the difficulty to treat the
nonmultiplying mycobacterial subpopulation. In order to assess the ability of (new) TB drugs …

[HTML][HTML] Advanced Quantification Methods To Improve the 18b Dormancy Model for Assessing the Activity of Tuberculosis Drugs In Vitro

ED Pieterman, MJ Sarink, C Sala, ST Cole… - Antimicrobial Agents …, 2020 - ncbi.nlm.nih.gov
One of the reasons for the lengthy tuberculosis (TB) treatment is the difficulty to treat the
nonmultiplying mycobacterial subpopulation. In order to assess the ability of (new) TB drugs …

Advanced Quantification Methods To Improve the 18b Dormancy Model for Assessing the Activity of Tuberculosis Drugs In Vitro

E Pieterman, MJ Sarink, C Sala, S Cole… - Antimicrobial Agents …, 2020 - repub.eur.nl
One of the reasons for the lengthy tuberculosis (TB) treatment is the difficulty to treat the
nonmultiplying mycobacterial subpopulation. In order to assess the ability of (new) TB drugs …

Advanced Quantification Methods To Improve the 18b Dormancy Model for Assessing the Activity of Tuberculosis Drugs In Vitro

ED Pieterman, MJ Sarink, C Sala… - Antimicrobial Agents …, 2020 - infoscience.epfl.ch
One of the reasons for the lengthy tuberculosis (TB) treatment is the difficulty to treat the
nonmultiplying mycobacterial subpopulation. In order to assess the ability of (new) TB drugs …

Advanced Quantification Methods To Improve the 18b Dormancy Model for Assessing the Activity of Tuberculosis Drugs In Vitro.

ED Pieterman, MJ Sarink, C Sala, ST Cole… - Antimicrobial agents …, 2020 - folia.unifr.ch
English One of the reasons for the lengthy tuberculosis (TB) treatment is the difficulty to treat
the nonmultiplying mycobacterial subpopulation. In order to assess the ability of (new) TB …

Advanced Quantification Methods To Improve the 18b Dormancy Model for Assessing the Activity of Tuberculosis Drugs In Vitro

E Pieterman, MJ Sarink, C Sala, ST Cole… - Antimicrobial Agents …, 2020 - repub.eur.nl
One of the reasons for the lengthy tuberculosis (TB) treatment is the difficulty to treat the
nonmultiplying mycobacterial subpopulation. In order to assess the ability of (new) TB drugs …